 |
 |
|
|
|
Coming Soon |
Coming Soon |
Coming Soon |
|
|
"Laney
College to offer Bio-tech certification"
"Laney answers call from Bio-tech" "CHORI Ventures” “MILLS COLLEGE OPENS MAJOR NATURAL SCIENCES BUILDING" Biotechnology
The Biotechnology Industry in Oakland and the East Bay is part of the
world’s largest and most vibrant biotech clusters in the world. In
the Oakland region, the biotech cluster is comprised of a variety of key
institutions and companies, including Novartis, Bayer Healthcare, Amyris
Biotechnologies Healthcare, Children’s Hospital Oakland Research
Institute (CHORI), Kaiser Permanente’s Division of Research as well as
the University of California Berkeley and the Lawrence Berkeley National
Laboratory.
Recent grants from industry and government to these institutions
have resulted in Oakland, Berkeley, and the East Bay becoming the
nexus for research, development, and commercialization in treating
and preventing human disease, as well as pushing out the frontier in
the research for alternative source of energy through biology.
Oakland’s strength in healthcare drives biotech research agenda
Oakland’s premier biomedical research institutions are on the
cutting edge
CHORI is the internationally renowned biomedical research institute of
Children's Hospital and Research Center at Oakland. Bridging basic
science and clinical research in the treatment and prevention of human
disease, CHORI is a leader in translational research, providing cures
for blood diseases, developing new vaccines for infectious diseases, and
discovering new treatment protocols for previously fatal or debilitating
conditions.
Striving to provide the highest standard of excellence and innovation,
CHORI brings together a multidisciplinary collaborative of distinguished
investigators in six different Centers of Research:
The Center for Cancer Research,
The Center for Genetics,
The Center for Immunobiology & Vaccine Development,
The Center for Nutrition & Metabolism,
The Center for Prevention of Obesity, Cardiovascular Disease & Diabetes,
and
The Center for Sickle Cell Disease & Thalassemia.
Kaiser Permanente’s Division of Research (DOR) conducts, publishes, and
disseminates high-quality epidemiologic and health services research to
improve the health and medical care of Kaiser Permanente members and the
society at large. It seeks to understand the determinants of illness and
well being and to improve the quality and cost-effectiveness of health
care. To accomplish these goals, the Division of Research is committed
to providing a supportive research environment that fosters independent
thinking, creativity, continued learning and adherence to the highest
scientific standards.
Oakland and the East Bay leads in biotech research and quest for
alternative energy focused on bio-fuels.
Recently, the Lawrence Berkeley National Laboratory was awarded
several large research grants to fuel the search for alternative
energies based on the East Bay’s strength in biotech research.
On February 1, 2007, global energy firm BP announced that it
selected the University of California, Berkeley, in partnership with
Lawrence Berkeley National Laboratory (LBNL) and the University of
Illinois at Urbana-Champaign, to lead an unprecedented $500 million
research effort to develop new sources of energy and reduce the
impact of energy consumption on the environment.
The funding will create the Energy Biosciences Institute (EBI),
which initially will focus its research on biotechnology to produce
bio-fuels — that is, turning plants and plant materials, including
corn, field waste, switch-grass and algae, into transportation fuels.
In addition, On June 26, 2007, Secretary of Energy Samuel W. Bod-man
announced a partnership of three national laboratories and three
research universities in the San Francisco Bay Area has been chosen
to host one of three bio-energy research centers, funded by the U.S.
Department of Energy (DOE) through its Biological and Environmental
Research Genomics: GTL research program in the Office of Science.
This new center will be known as the DOE Joint Bio-Energy Institute
(JBEI) and is expected to receive $125 million in DOE funding over
five years.
The DOE JBEI’s six partners are the Lawrence Berkeley National
Laboratory (Berkeley Lab), Sandia National Laboratories (Sandia),
the Lawrence Livermore National Laboratory (LLNL), the University of
California (UC) campuses of Berkeley and Davis, and Stanford
University. Plans call for the DOE JBEI to be headquartered in a
leased building in the East Bay, central to all partners.
The central task of the Oakland Metropolitan Chamber of Commerce,
Mayor Ron Dellums of Oakland and the entire Oakland Partnership will
be to ensure that Oakland and the East Bay are well position to be
home to the companies that will commercialize the technologies
emerge from this enormous research effort.
To do this, members of the Oakland Partnership, led by Dr. Bertram
Lubin, the Director of Children’s Hospital Oakland Research
Institute (CHORI); and Dr. Vipul Mankad, Chief Medical Officer of
Children’s Hospital, are working together to ensure the real estate,
workforce, and other infrastructure is in place to continue and
strengthen Oakland and the East Bay’s dominant position in this
industry. |
 |